Adient ADNT Change in net unrealized gain (loss) on derivative instruments

Change in net unrealized gain (loss) on derivative instruments at other companies

GTY

Getty RealtyGTY

$1.66M-21.2%

Avanos MedicalAVNS

$1.5M+1,600%

BlackbaudBLKB

$3.58M+153%

CBIZCBZ

$1.99M+253%

John Wiley & Sons, Inc.WLYB

$949K+129%

HNIHNI

$600K+200%

Other financials

Income statement

See full

Revenue$3.9B+7.0%

Gross profit$257.0M-1.5%

Net income$27.0M+108%

EPS (diluted)$0.34+109%

Balance sheet

See full

Cash & equivalents$831.0M+10.2%

Total debt$2.6B+0.3%

Total equity$1.7B+3.7%

Total assets$9.0B+5.2%

Cash flow

See full

Operating cash flow$81.0M—

CapEx$73.0M+62.2%

Free cash flow$8.0M+109%

Valuation

See full

Market cap$1.59B+46.7%

Enterprise value$3.39B+14.7%

P/E38.8×—

P/S0.1×0.0×

Profitability

See full

Gross margin6.4%0.0pp

Net margin0.3%+0.1pp

FCF margin1.8%+0.2pp

Returns & leverage

See full

Return on equity2.4%+1.3pp

Debt / equity1.5×-0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Adient in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent.

The official record: Adient’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adient's change in net unrealized gain (loss) on derivative instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adient's change in net unrealized gain (loss) on derivative instruments?: Adient (ADNT) reported change in net unrealized gain (loss) on derivative instruments of -$22M in Q1 2026.
How has Adient's change in net unrealized gain (loss) on derivative instruments changed year-over-year?: Adient's change in net unrealized gain (loss) on derivative instruments decreased by 229.4% year-over-year, from $17M to -$22M.